OCT-B101

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameOCT-B101
Drug Alias NameOCT-B101
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionBone resorption inhibitorsBone synthesis stimulants
TargetsUpdating
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOscotec Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOscotec Inc
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A